logo
ENTITY

Xencor Inc (XNCR US)

7
Analysis
Health Care • United States
Xencor, Inc. develops antibody and protein therapeutics to treat cancer and autoimmune inflammation. The Company markets its products to healthcare providers and facilities throughout the United States and internationally.
more
Refresh
Exchange Announcement • 09 Apr 2024 20:20

Current Report (Form 8-K | Period ending 2024-04-09)

Exchange Announcement • 06 Mar 2024 21:32

Current Report (Form 8-K | Period ending 2024-03-06)

Exchange Announcement • 29 Feb 2024 08:00

Annual Report (Form 10-K | Period ending 2023-12-31)

Exchange Announcement • 28 Feb 2024 05:05

Current Report (Form 8-K | Period ending 2024-02-27)

Exchange Announcement • 17 Feb 2024 05:06

Statement of changes in beneficial ownership (Form 4 | Period ending 2024-02-14)

Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.30.2

x